Tracy Chia-Chien Kuo

This inventor holds 21 USPTO granted patents and 12 published patent applications, plus 2 CIPO patents and 8 EPO patents, primarily in Cancer Immunotherapy. Top assignees: Alx Oncology Inc., Pfizer Corporation, Tallac Therapeutics, Inc.. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tracy Chia-Chien Kuo. Retrieved from https://idiyas.com/inventor/tracy-chia-chien-kuo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 12)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 12)

EPO Patents = 8 (Patent Applications = 16)

Average Co-Inventor Count = 7.1

ph-index = 5

Forward Citations = 75(Granted Patents)

Location History:

San Mateo, CA (US) (2018 - 2024)
San Carlos, CA (US) (2021 - 2024)

Company Filing History:

Tallac Therapeutics, Inc.

patents

Years Active: 2018-2026

Loading Chart...

Areas of Expertise:

Cancer Treatment

Therapeutic Antibodies

Chimeric Antigen Receptors

Signal-Regulatory Protein Alpha

Combination Therapies

Transglutaminase-Mediated Conjugation

B-Cell Maturation Antigen

Constructs

Gastric Cancer

Gastroesophageal Junction Cancer

Immunotherapy

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12527838 - COMBINATION THERAPIES COMPRISING AN AGENT THAT BLOCKS THE INTERACTION BETWEEN CD47 AND SIRPa FOR TREATING GASTRIC OR GASTROESOPHAGEAL JUNCTION CANCER (2026-01-20),

2. 12404340 - Antibodies against signal-regulatory protein alpha and methods of use (2025-09-02),

3. 12098214 - Combination therapies for treating cancer (2024-09-24),

4. 11939393 - Antibodies against signal-regulatory protein alpha and methods of use (2024-03-26),

5. 11920136 - Transglutaminase-mediated conjugation (2024-03-05),

6. 11912776 - Chimeric antigen receptors targeting B-cell maturation antigen (2024-02-27),

7. 11814435 - Therapeutic antibodies and their uses (2023-11-14),

8. 11795463 - Transglutaminase-mediated conjugation (2023-10-24),

9. 11639376 - Constructs having a SIRP-α domain or variant thereof (2023-05-02),

10. 11401338 - Antibodies against signal-regulatory protein alpha and methods of use (2022-08-02),

11. 11312782 - Chimeric antigen receptors targeting B-cell maturation antigen (2022-04-26),

12. 11292850 - Antibodies against signal-regulatory protein α and methods of use (2022-04-05),

13. 11242404 - Antibodies against signal-regulatory protein alpha and methods of use (2022-02-08),

14. 11208459 - Constructs having a SIRP-alpha domain or variant thereof (2021-12-28),

15. 11155630 - Therapeutic antibodies and their uses (2021-10-26),

Title: Tracy Chia-Chien Kuo - The Innovative Mind from San Mateo

Introduction: Tracy Chia-Chien Kuo is a visionary inventor based in San Mateo, California, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Tracy Chia-Chien Kuo holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing his diverse range of expertise and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Tracy Chia-Chien Kuo has worked with leading tech companies, research institutions, and universities, driving innovation and pushing the boundaries of what is possible in the tech industry.

Collaborations: Tracy Chia-Chien Kuo has collaborated with top engineers, scientists, and researchers from around the world, fostering a culture of creativity and excellence in all his projects. His collaborative spirit has led to the development of cutting-edge technologies that have the potential to shape the future.

Conclusion: Tracy Chia-Chien Kuo's passion for innovation, coupled with his relentless drive to create a positive impact on society, solidifies his position as a trailblazer in the world of technology and invention.

Profile summary based on public USPTO records.